Role of platelet adhesion in homeostasis and immunopathology

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 4, 1997, Pages 175-185

  Männel, Daniela N ^a   Grau, Georges E ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cell adhesion molecules; Immunopathology; Platelet adhesion

Indexed keywords

CD31 ANTIGEN; CD36 ANTIGEN; CELL ADHESION MOLECULE; FIBRINOGEN RECEPTOR; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR;

BRAIN MALARIA; CELL INTERACTION; CELL TYPE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; LUNG FIBROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK; THROMBOCYTE ADHESION;

EID: 0030700656     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.4.175     Document Type: Review

References (125)

1. Nurden AT, Nurden P. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction. Baillieres Clin Haematol 1993;6:653-90.
2. Shattil SJ. Regulation of platelet anchorage and signaling by integrin alpha-IIb-beta-3, Thromb Haemost 1993;70:224-8.
3. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994;6:695-704.
4. Li JM, Podolsky RS, Rohrer MJ, Cutler BS, Massie MT, Barnard MR, et al. Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. J Surg Res 1996;61:543-8.
5. Calvete JJ. On the structure and function of platelet integrin alpha IIb beta 3, the fibrinogen receptor. Proc Soc: Exp Biol Med 1995;208:246-360.
6. Hawiger J. Mechanisms involved in platelet vessel wall interaction. Thromb Haemost 1995;74:369-72.
7. Rang J, Cabral C, Kushner L, Salzman EW. Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation. Blood 1993;81:1505-12.
8. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996;47:315-31.
9. Knezevic I, Leisner TM, Lam SCT. Direct binding of the platelet integrin alpha(IIb)beta(3) (GPIIb-IIIa) to talin - Evidence that interaction is mediated through the cytoplasmic domains of both alpha(IIb) and beta(3). J Biol Chem 1996;271:16416-21.
10. Frojmovic MM, O'Toole TE, Plow EF, Loftus JC, Ginsberg MH. Platelet glycoprotein Ilb-IIIa (alpha-IIb-beta-3 integrin) confers fibrinogen- and activation-dependent aggregation on heterologous cells. Blood 1991;78:369-76.
11. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B, The platelet glycoprotein-IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993;70:514-521.
12. Spangenberg P. Adhesion of activated platelets to polymorphonuclear leukocytes. Thromb Res 1994;74:S35-44.
13. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis - a causal relationship. Cancer Metastasis Rev 1992;11:325-51.
14. Honn KV, Tang DG. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 1992;11:353-75.
15. 5 Adams JC, Lawler J. Diverse mechanisms for cell attachment to platelet thrombospondin. J Cell Sci 1993;104: 1061-71.
16. Boukerche H, Berthiervergnes O, Tabone E, Bailly M, Dore JF, Mcgregor JL. Thrombospondin modulates melanomaplatelet interactions and melanoma tumour cell growth in vivo. Br J Cancer 1995;72:108-16.
17. Suehiro K, Smith JW, Plow EF. The ligand recognition specificity of beta3 integrins. J Biol Chem 1996;271:10365-71.
18. Cox D, Motoyama Y, Seki J, Aoki T, Dohi M, Yoshida K. Pentamidine - a non-peptide GPIIb/IIIa antagonist-invitro studies on platelets from humans and other species. Thromb Haemost 1992;68:731-6.
19. Freed MI, Boike S, Zariffa N, Jorkasky DK. Effects of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonist. Thromb Haemost 1994;72:622-6.
20. Mousa SA, Bozarth JM, Forsythe MS, Lorelli W, Thoolen MJ, Ramachandran N, et al. Antiplatelet efficacy and specificity of Dmp728, a novel platelet Gpiib/Iiia receptor antagonist. Cardiology 1993;83:374-82.
21. Nicholson NS, Panzerknodle SG, King LW, Taite BB, Keller BT, Tjoeng FS, et al. SC-49992 - A potent and specific inhibitor of platelet aggregation. Thromb Res 1994;74:523-35.
22. Rubsamen K, Hornberger W, Kirchengast M. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin- inhibitor r-hirudin, and the glycoprotein IIb/ IIIa-receptor antagonist Ro 43-8857. Thromb Haemost 1995;74:1353-60.
23. Juliano D, Wang YQ, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S. Disintegrin interaction with alpha(v)beta(3) integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta(3) subunit. Exp Cell Res 1996;225:132-42.
24. Karczewski J, Waxman L, Endris RG, Connolly TM. An inhibitor from the argasid tick Ornithodoros moubata of cell adhesion to collagen. Biochem Biophys Res Commun 1995;208:532-41.
25. Beumer S, Ijsseldijk MJW, Degroot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood 1994;84:3724-33.
26. Zahger D, Fishbein MC, Garfinkel LI, Shah PK, Forrester JS, Regnstrom J, et al. VCL, an antagonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat. Circulation 1995;92:1269-73.
27. Kamat SG, Michelson AD, Benoit SE, Moake JL, Rajasekhar D, Heliums JD, et al. Fibrinolysis inhibits shear stress-induced platelet aggregation. Circulation 1995;92: 1399-407.
28. Hsu-Lin SC, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation. J Biol Client 1984;259:9121-6.
29. Larsen E, Cell A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-12.
30. Boukerche H, Ruchaud Sparagano MH, Rouen C, Brochier J, Kaplan C, Mcgregor JL. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140 PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol 1996;92:442-51.
31. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995;92:7450-4.
32. Moore KL, Patel KD, Bruehl RE, Li FG, Johnson DA, Lichenstein HS, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995;128:661-71.
33. Cooling LL, Zhang DS, Walker KE, Koerner TA. Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins. Glycobiology 1995;5:571-581.
34. Weyrich AS, Elstad MR, Mcever RP, Mcintyre TM, Moore KL, Morrissey JH, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996;97: 1525-34.
35. Kuijper PHM, Torres HIG, Vanderlmden JAM, Lammers JWJ, Sixma JJ, Koenderman L, et al. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 1996;87:3271-81.
36. Diacovo TG, Puri KD, Warnock RA, Springer TA, Vonandrian UH. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996;273:252-5.
37. Halvorsen H, Olsen JO, Osterud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukocyte Biol 1993;54:275-82.
38. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, et al. P- and E-solectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997;385:81-3.
39. Aigner S, Ruppert M, Hubbe M, Sammar M, Sthoeger Z, Butcher EC, et al. Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol 1995;7:1557-65.
40. Sammar M, Aigner S, Hubbe M, Schirrmacher V, Schachner M, Vestweber D, et al. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol 1994; 6:1027-36.
41. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA. CD31/PECAM-1 is a ligand for alpha(v)beta(3) integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995;130:451-60.
42. Baldwin HS, Shen HM, Van HC, Delisser HM, Chung A, Mickanin C, et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1 CD31): alternatively spliced, functionally distinct isofurms expressed during mammalian cardiovascular development. Development 1994;120:2539-53.
43. Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang JM, Shih CCY. Role of platelet-endothehal cell adhesion molecule (PECAM) in platelet adhesion aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 1996;27:709-11.
44. Bogen S, Pak J, Garifallou M, Deng XH, Muller WA. Monoclonal antibody to murine pecam-1 (Cd31) blocks acute inflammation in vivo. J Exp Med 1994;179:1059-64.
45. Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 1996;156:3550-7.
46. Rosenblum WI, Murata S, Nelson GH, Werner PK, Ranken R, Harmon RC. Anti-CD31 delays platelet adhesion aggregation at sites of endothelial injury in mouse cerebral arterioles. Am J Pathol 1994;145:33-6.
47. McCaffery PJ, Berridge MV. Expression of the leukocyte functional molecule (LFA-1) on mouse platelets. Blood 1986;67:1757-64.
48. Grau GE, Tacchini-Cottier F, Vesin C, Milon G, Lou J, Piguet PF, et al. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ ICAM-1 interaction. Eur Cytokine Netw 1993;4:415-19.
49. Piguet PF, Vesin C, Ryser JE, Senaldi G, Grau GE, Tacchini-Cottier F. An effector role of platelets in the local or systemic LPS-induced toxicity mediated by a CD11/ CD18 dependent interaction with the endothelium. Infect Immun 1993;61:4182-7.
50. Piguet PF, Rosen H, Vesin C, Grau GE. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD11 antibodies. Am Rev Respir Dis 1993; 147:435-41.
51. Piguet PF, Vesin C. Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta2 integrins. Int J Exp Pathol 1994;75:321-8.
52. Avraham H, Cowley S, Chi SY, Jiang SX, Groopman JE. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J Clin Invest 1993;91:2378-84.
53. Philippeaux MM, Vesin C, Tacchinicottier F, Piguet PF. Activated human platelets express beta 2 integrin. Eur J Haematol 1996;56:130-7.
54. Schattner MA, Finiasz MR, Notrica JA, Lazzan MA. Platelet aggregation inhibition by mononuclear leukocytes. Thromb Res 1994;73:205-14.
55. Diacovo TG, Defougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intercellular adhesion molcculc-2. J Clin Invest 1994;94: 1243-51.
56. Vanschravendijk MR, Handunnetti SM, Barnwell JW, Howard RJ. Normal Human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood 1992;80:2105-14.
57. Daviet L, Mcgregor JL. Functional roles of membrane glycoprotein CD36. Platelets 1996;7:117-24.
58. Aiken ML, Ginsberg MH, Byersward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein-IV, on Platelet aggregation and thrombospondin surface expression. Blood 1990;76:2501-9.
59. Saelman HUM, Kehrel B, Hese KM, Degroot PG, Sixma JJ, Nieuwenhuis HK. Platelet adhesion in collagen and endnthehal cell matrix under How conditions is not dependent on platelet glycoprotein IV. Blood 1994;83: 3240-4.
60. Agbanyo FR, Sixma JJ, Oegroot PG, Languino LR, Plow EF. Thrombospondin piatelet interactions role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 1993;92:288-96.
61. Gao AG, Lindberg FP, Dimitry JM, Brown FJ, Frazier WA. Thrombospondin modulates alpha(v)beta(3) function through intcgrin-assodared protein. J Cell Biol 1990;135: 533-44.
62. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992;90:1513-22.
63. Puente-Navazo MD, Daviet L, Savill J, Ren Y, Leung LL, Mcgregor JL. Identification of a domain (155-183) on CD 36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 1996;271:15381-5.
64. Franc NC, Dimareq JL, Lagueux M, Huffmann J, Ezekowitz RA. Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity 1996;4:431-43.
65. Spycher MO, Nydegger UE. Participation of the blood platelet in immune reactions due to platelet-complement interaction. Infusionstlier Transfusionsmed 1995;22:36-43.
66. Colman RW. Receptors that activate platelets. Proc Soc Exp Biol J 1991;197:242-8.
67. Darius H, Binz C, Veit K, Fisch A, Meyer J. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion. J Am Coll Cardiol 1995;26:800-6.
68. Copley AL, Witte S. On physiological microthromboembolization as the primary platelet function, elimination of invaded particles from the circulation and its pathogenic significance. Thromb Res 1976;8:251-62.
69. Johnson SA, Balboa RS, Dessel BH, Monto RW, Siegesmund KA, Greenwalt TJ. The mechanism of the enelothelial supporting function of intact platelets. Exp Mol Pathol 1964;3:115-27.
70. Wojcik JD, Van Horn DL, Webber AJ, Johnson SA. Mechanism whereby platelets support the endnthelium. Tranasfusion 1969;9:324-35.
71. Gimbrone MAJ, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222:33-6.
72. Kent KC, Wroblewski L, Jackman RW, Skillman JJ. Platelet attachment stimulates endothelial cell regeneration after arterial injury. Surgery 1995;117:276-81.
73. Philippe C, Philippe B, Fouqueray B, Perez J, Lebret M, Baud L. Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol 1993;143:1713-23.
74. Sagawa T, Kodama T, Tominaga A, Okada M. Human platelets effectively kill K-562 cells, a chronic myelogenic leukemia cell line, in vitro. Jpn J Cancer Res 1990;81:449-53.
75. Peyron F, Polack B, Lamotte D, Kolodie L, Ambroisethomas P. Plasmodium-falciparum growth inhibition by human platelets invitro. Parasitology 1989;99:317-22.
76. Polack B, Peyron F, Kolodie L, Ambroisethomas P, Santoro E. Platelet receptors involved in plasmodium-falciparum growth inhibition. Thromb Res 1990;59:663-7.
77. Yong EC, Chi EY, Fritsche TR, Henderson WR. Human platelet-mediated cytoloxicity against Toxoplasma gondii: role of thromboxane. J Exp Med 1991;173:65-78.
78. Damonneville M, Pancre V, Capron A, Auriault C. Protection of rats against schistosuma-mansoni infection induced by platelets stimulated with the murme recombinant tumor necrosis factor-alpha, Int Arch Allergy Appl Immunol 1990; 92:361-3.
79. Pancre V, Joseph M, Mazingue C, Wietzerbin J, Capron A, Auriault C. Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol 1987; 138:4490-5.
80. Joseph M, Capron A, Ameisen JC, Capron M, Vorng H, Pancre V, et al. The receptor for IgH on blood platelets. Eur J Immunol 1986;16:306-12.
81. Fajardo LF, Tallent C. Malarial parasites within human platelets. JAMA 1974;229:1205.
82. Kelton JG, Keystone J, Moore J, Denomme G, Tozman E, Glynn M, et al. Immune-mediated thromhocytopenia of malaria. J Clin Invest 1983;71:832-6.
83. Beale PJ, Cormack JD, Oldrey TBN. Thrombocytopenia in malaria with immunoglobulin (IgM) changes. BMJ 1972;i: 345-9.
84. Grau GE, Piguet PF, Gretener D, Vesin C, Lambert PH. Immunopathology of thrombocytopenia in experimental malaria. Immunology 1988;65:501-6.
85. Cooke BM, Nash GB. Plasmodium falciparum: characterizatittn of adhesion of flowing parasitized red blood cells to platelets. Exp Parasitol 1995;80:116-23.
86. Cooke BM, Berendt AR, Craig AG, Macgregor J, Newbold CI, Nash GB. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br J Haematol 1994;87:162-70.
87. Grau GE, Piguet PF. Tumor necrosis factor in cerebral and non-cerebral malaria. In: Fiers W, Buurman WA, eds. Tumor necrosis factor: molecular and cellular biology and clinical relevance. Basel: Karger, 1993:162-71.
88. Grau GE, Pointaire P, Piguet PF, Vesin C, Rosen H, Stamenkovic I, et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol 1991;21:2265-7.
89. Falanga PB, Butcher EC. Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model. Eur J Immunol 1991;21:2259-63.
90. Pongponratn F, Riganti M, Harinasuta T, Runnag D. Electron microscopy of the human brain in cerebral malaria. Southeast Asian J Trop Med Public Health 1985;16:219-27.
91. Grau GE, Lou J. TNF in vascular pathology: importance of platelet-endothelium interactions. Res Immunol 1993;144: 355-63.
92. Lucas R, Juillard P, Decoster E, Redard M, Burger D, Donati YRA, et al. Crucial role of TNF receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol [In press.)
93. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993;46:37-40.
94. Grau GE, Lou JN. TNF-induced microvascular pathology in the TH1-mediated lesions of mouse cerebral malaria possible new mechanisms. In: Romagnani S, DelPrete G, Abbas AK, eds. Cytokines: basic principles and clinical applications. Rome: Ares-Serono Symposia, 1994:265-79.
95. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated Platelets express IL-1 activity. J Immunol 1989;143:4015-18.
96. Hawrylowicx CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991;174:785-90.
97. Heffner JH, Sahn SA, Repine JK. The role of platelets in the adult respiratory distress syndrome. Culprits or bystanders? Am Rev Respir Dis 1987;135:482-92.
98. Bredenberg CM, Taylor GA, Webb WR. The effect of thriimbocytopenia on the pulmonary and systemic hemodynarnics of canine endotoxin shock. Surgery 1980;87:59-68.
99. Endo V, Kakamura M. The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br J Pharmacol 1992;105:613-19.
100. Rylander R, Bake B, Fischer JJ, Helander IM. Pulmonary Function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989;140:981-6.
101. Sigurdsson GH, Youssef H. Effects of pentoxifylline on hemodynamics, gas exchange and multiple organ platelet sequestration in experimental endotoxic shock. Acta Anaesthesiol Scand 1993;37:396-403.
102. Endo Y, Nakamura M. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor, Gen Pharmacol 1993;24:1039-53.
103. Itoh H, Cicala C, Douglas GJ, Page CP. Platelet accumulation induced by bacterial endotoxin in rats. Thromb Res 1996;83:405-19.
104. Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978;92:525-617.
105. Csako G, Suba HA, Elin RJ. Endotoxin-inducecl platelet activation in human whole blood in vitro, Thromb Haemost 1998;59:378-82.
106. Cybulsky MI, Chan MK, Movat HZ. Acute inflammation and inierothrombosis induced by endtitoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 1988;58:365-78.
107. Libert C, Brouckaert P, Fiers W. Protection by alpha(1)-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 1994;180:157-5.
108. Sigurdsson GH, Youssef HAF, Owunmwanne A. Effects of two different inhibitors of the arachidonic acid metabolism on platelet sequestration in endotoxic shock. Res Exp Med 1994;194:287-95.
109. Tighe D, Moss R, Heywood G, al Saady K, Webb A, Bennett D. Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. Crit Care Med 1995;23:1997-2007.
110. Gawaz M, Fatehmoghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995;25:843-51.
111. Piguet PF, Vesin C, Thomas F. Bombesin down modulates pulmonary ribrosis elicited in mice by bleomycin. Exp Lung Res 1995;21:227-37.
112. Stoelcker B, Hafner M, Orosz P, Nieswandt B, Mannel DN. Role of adhesion molecules and platelets in TNF-induced adhesion of tumor cells to endothelial cells: implications for experimental metastasis. J Inflamm 1996;46: 155-67.
113. Mannel DN, Orosz P, Hafner M, FaJk W. Mechanisms involved in metastasis enhanced by inflammatory mediators. Circ Shock 1994;44:9-13.
114. Honn KV, Tang DG, Grossi IM, Renaud C, Duniec ZM, Johnson CR, et al. Enhanced endothelial cell retraction mediated by 12(S)- HETE a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 1994;210:1-9.
115. Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of thrombospondin membrane receptor. J Clin Invest 1987;79:11154-61.
116. Felding Habermann B, Habermann R, Saldivar E, Ruggeri ZM. Role of beta 3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem 1996;271:5892-900.
117. Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins. Int J Cancer 1997;70:201-7.
118. Sarach MA, Rovasio RA, Eynard AR. Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities. Int J Exp Pathol 1993;74:511-17.
119. Yahalom J, Eldor A, Fuks Z, Vlodavsky I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest 1984;74:1842-9.
120. Belloc C, Lu H, Soria C, Fridman R, Legrand Y, Menashi S. The effect of platelets on invasiveness and protease pro- duction of human mammary tumor cells. Int J Cancer 1995;60:413-17.
121. Gordon JL, Milner AJ. Blood platelets as multifunctional cells. In: Gordon JL, ed. Platelets in biology and pathology. Amsterdam: North Holland, 1979:3-22.
122. Candinas D, Lesnikoski BA, Hancock WW, Otsu I, Koyamada N, Dalmasso AP, et al. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts. Transplantation 1996;62:1-5.
123. Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Rev 1996;8:11-94.
124. Said S, Rosenblum WI, Povlishock JT, Nelson GH. Correlations Between morphological changes in platelet aggregates and underlying endothelial damage in cerebral microcirculation of mice. Stroke 1993;24:1968-76.
125. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, Delzoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994;25:202-11.